Initial Application for trading on US OTCQB
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
28 April 2021
CYBA plc ("CYBA" or the "Company")
Initial Application made for trading of CYBA shares on the US OTCQB Market
CYBA plc ("CYBA" or the "Company") is pleased to announce that it has submitted its application form into OTC Markets for the Company's ordinary share capital to cross-trade on the OTC Market's OTCQB ('OTCQB") trading platform in the United States of America (the "US").
Trading on the US OTC market would make CYBA's shares more widely available to North American Investors, whilst having no impact on existing Cyba ordinary shares trading on the Main Market of the London Stock Exchange. No new ordinary shares will be issued as part of the cross-trade. Cyba will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and will have no Sarbanes-Oxley or SEC reporting requirements. A further announcement will be made in due course.
ENDS
For further information on the Company please visit www.cybaplc.com, with the Company's Prospectus to be found at www.cybaplc.com/Investorrelations/prospectus or contact:
|
Robert Mitchell
|
CYBA |
Tel: +44 (0) 20 3468 2212 |
|
Peter Krens |
Tennyson Securities |
Tel: +44 (0)207 186 9030 |
|
Catherine Leftley / Frank Buhagiar |
St Brides Partners Ltd, Financial PR
|
Tel: +44 (0)207 236 1177 info@stbridespartners.co.uk |
About CYBA plc
CYBA plc ("CYBA") is a special purpose acquisition company ("SPAC") seeking suitable acquisition targets in the Cyber Security sector.
CYBA intends to implement its strategy focussed on building a group capable of offering Cyber and Cybersecurity solutions in the US and globally.
The Company intends to leverage the deep industry knowledge of its board and associates to undertake due diligence on the commercial attributes of a target entity's business.
Further information in respect of the Company and its business interests is provided on the Company's website at www.cybaplc.com
Forward-looking statements
Certain statements in this announcement constitute ''forward-looking statements''. Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words ''anticipates'', ''estimates'', ''expects'', ''believes'', ''intends'', ''plans'', ''may'', ''will'', ''should'', and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 6 hours ago Luceco
- 6 hours ago Helios Towers
- 7 hours ago Wise Class A
- 7 hours ago EDX Medical Group Plc
- 7 hours ago Naked Wines